Dallas, TX, Oct. 11, 2018 (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB: NXNN), a neurostimulation medical device company, announces…
Nexeon Announces Submission for FDA Innovation Challenge
Nexeon MedSystems Receives $830,000 grant from the National Institute of Neurological Disorders and Stroke
Dallas, TX, Sept. 25, 2018 (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (“Nexeon”) (OTCQB:NXNN), a neurostimulation medical device company, announced that…